Federal Council introduces measures to counter shortages of essential medical supplies for combating the COVID-19 pandemic

Range of measures to improve the availability of essential medical supplies for preventing and combating the coronavirus disease (COVID-19)


Placing on the market of important medical devices for combating the COVID-19 pandemic

Exemptions for non-conforming medical devices


DHPC – Esmya (Ulipristalacetat)

Risiko für Leberschädigung


Nachtrag 10.1 der Europäischen Pharmakopöe in Kraft

Der Institutsrat hat den Nachtrag 10.1 der Europäischen Pharmakopöe auf den 1. April 2020 in Kraft gesetzt.

In focus



Coronavirus disease (COVID-19) Pandemic

Information on the new coronavirus (SARS-CoV-2)

Medical devices
New EU regulations (MDR, IVDR)

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

Direct links

Stay up to date

Incident reporting


Reporting undesirable effects

Medical devices

Reporting incidents & FSCAs




Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019


What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.

Swissmedic, Swiss Agency for Therapeutic Products


Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...